Navigation Links
New study quantifies total costs of fragility fractures in 6 major European countries
Date:3/24/2011

Research presented today at the European Congress on Osteoporosis & Osteoarthritis by investigators from the UK and Sweden estimates that the economic burden of fragility fractures in five major European countries totals 31 billion Euro, with Germany bearing the highest costs. A majority of the economic burden is shown to be related to the costs incurred during the 1st year after the fracture, while pharmacological prevention and treatment management constitutes only a marginal share of the total economic cost.

Hip fractures contributed 56% to the overall costs, vertebral fractures 5%, wrist fractures 2% and a combined group of "other" fractures represented 37% of the total. Costs in Germany totaled 9.37 billion Euro, followed by Italy at 6.7 and the UK at 5.8 billion Euro.

The total annual economic burden of all fragility fractures in the six countries studied was found to be 31 billion Euro.

IOF President John Kanis, co-author of the study, stated, "Fragility fractures due to osteoporosis cause pain and disability, often having a severe impact on the quality of life of millions of Europeans. This important study reveals the enormous economic cost of fragility fractures. Prevention of fractures through early risk assessment and identification of those in need of treatment is the key to reducing the costs to national health care systems throughout Europe."


'/>"/>

Contact: L. Misteli
info@iofbonehealth.org
International Osteoporosis Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. Study finds remarkable diversity of lichen species in Florida state park
2. UC Riverside geneticists to study how plants adapt to a changing environment
3. Experimental radioprotective drug safe for lung cancer patients, says Pitt study
4. Evolutionary winners and losers revealed in collaborative study
5. Study finds that overweight people really are big-boned
6. Study indicates vitamin A plays key role in the human body
7. Study provides new tool to monitor coral reef vital signs
8. New study pinpoints why some microbial genes are more promiscuous than others
9. Bacterial wipes research study
10. MU researcher leads new $6.6 million study that could lead to better corn plants
11. A research study analyzes marine spill prevention policies in Spain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... --  EyeLock LLC , a market leader of iris-based ... IoT Center of Excellence in Austin, Texas ... embedded iris biometric applications. EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... 2016 , ... While the majority of commercial spectrophotometers and fluorometers use the ... models are higher end machines that use the more unconventional z-dimension of 20mm. ... the bottom of the cuvette holder. , FireflySci has developed several Agilent flow ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
Breaking Biology Technology: